This study has demonstrated, for the first time, that there exists a clonal dominance of the CD133 stemness marker within the hierarchy of cells in the cutaneous tissues from patients that have undergone successive progressive stages of melanoma, from primary to metastatic lesions. This evidence concerns the gene PROM1 and melanoma.